We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+0.26%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.02B
AUM Growth
-$114M
Cap. Flow
-$94.8M
Cap. Flow %
-1.89%
Top 10 Hldgs %
21.21%
Holding
229
New
6
Increased
67
Reduced
121
Closed
10

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$20M
2
GSK icon
GSK
GSK
+$16.8M
3
ZBH icon
Zimmer Biomet
ZBH
+$10.6M
4
BABA icon
Alibaba
BABA
+$9.06M
5
IR icon
Ingersoll Rand
IR
+$8.21M

Top Sells

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$39.2M
2
ECL icon
Ecolab
ECL
+$28M
3
VFC icon
VF Corp
VFC
+$27.9M
4
CERN
Cerner Corp
CERN
+$18.2M
5
AABA
Altaba Inc
AABA
+$17.2M

Sector Composition

Rank Sector Weight
1 Financials 22.58%
2 Technology 13.72%
3 Industrials 13.39%
4 Healthcare 12.82%
5 Consumer Discretionary 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAYX icon
176
Paychex
PAYX
$42.7B
$365K 0.01%
4,406
+250
+6% +$20.8K
TGT icon
177
Target
TGT
$66.9B
$362K 0.01%
3,387
MNST icon
178
Monster Beverage
MNST
$89.6B
$354K 0.01%
12,192
MO icon
179
Altria Group
MO
$114B
$331K 0.01%
8,091
-2,261
-22% -$104K
NVO
180
Novo Nordisk
NVO
$208B
$331K 0.01%
12,800
HSY icon
181
Hershey
HSY
$36.8B
$315K 0.01%
2,031
+100
+5% +$15.1K
TRV icon
182
Travelers Companies
TRV
$80B
$313K 0.01%
2,104
+24
+1% +$3.57K
BAX icon
183
Baxter International
BAX
$14.1B
$300K 0.01%
3,430
+54
+2% +$4.61K
BN icon
184
Brookfield
BN
$108B
$292K 0.01%
15,415
GILD icon
185
Gilead Sciences
GILD
$166B
$292K 0.01%
4,605
-655
-12% -$42.8K
CTSH icon
186
Cognizant
CTSH
$25.7B
$290K 0.01%
4,809
-4,650
-49% -$294K
PNC icon
187
PNC Financial Services
PNC
$101B
$270K 0.01%
1,929
-179
-8% -$24.3K
HUBB icon
188
Hubbell
HUBB
$27.3B
$269K 0.01%
2,050
CVS icon
189
CVS Health
CVS
$122B
$265K 0.01%
4,195
+257
+7% +$15.2K
NFLX icon
190
Netflix
NFLX
$309B
$264K 0.01%
9,880
-100
-1% -$3.13K
DOW icon
191
Dow Inc
DOW
$21.5B
$260K 0.01%
5,465
-17
-0.3% -$796
LMT icon
192
Lockheed Martin
LMT
$134B
$260K 0.01%
667
+8
+1% +$3.01K
AMTD
193
DELISTED
TD Ameritrade Holding Corp
AMTD
$248K ﹤0.01%
5,315
-96,150
-95% -$4.61M
PGR icon
194
Progressive
PGR
$124B
$244K ﹤0.01%
3,163
RDS.A
195
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$235K ﹤0.01%
3,998
+384
+11% +$22.8K
BKNG icon
196
Booking.com
BKNG
$161B
$222K ﹤0.01%
2,825
NEE icon
197
NextEra Energy
NEE
$177B
$222K ﹤0.01%
+3,808
New +$206K
BP icon
198
BP
BP
$108B
$221K ﹤0.01%
5,805
-420
-7% -$16K
BLK icon
199
Blackrock
BLK
$176B
$217K ﹤0.01%
488
-12
-2% -$5.34K
BUD icon
200
AB InBev
BUD
$166B
$214K ﹤0.01%
2,250
-250
-10% -$23.7K

Similar funds

Douglas Lane & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Douglas Lane & Associates held 229 positions worth $5.02B, down 2.2% from $5.13B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Douglas Lane & Associates's Q3 2019 filing shows 6 new, 67 increased, 121 reduced and 10 closed positions. Its largest new stake was GSK: 325,630 shares worth $17.4M. The largest sale was Dentsply Sirona, an estimated $39.2M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q3 2019 buy was GSK: 325,630 shares worth $17.4M.
  • Douglas Lane & Associates added most to Electronic Arts in Q3 2019, an estimated $20M increase.
  • Douglas Lane & Associates's biggest Q3 2019 reduction was Dentsply Sirona, cutting an estimated $39.2M.
  • Douglas Lane & Associates fully exited Altaba Inc in Q3 2019, selling an estimated $17.2M.
  • Douglas Lane & Associates's ten largest holdings make up 21% of its $5.02B portfolio in Q3 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 10 in Q3 2019.
  • Douglas Lane & Associates's portfolio value fell 2.2% quarter-over-quarter to $5.02B.

Based on Douglas Lane & Associates's 13F filing for Q3 2019, filed 16 Oct 2019.